Background and methods: Magnetic iron oxide nanoparticles were prepared using a sonochemical method under atmospheric conditions at a Fe2+ to Fe3+ molar ratio of 1:2. The iron oxide nanoparticles were subsequently coated with chitosan and gallic acid to produce a core-shell structure. Results: X-ray diffraction demonstrated that the magnetic nanoparticles were pure Fe3O4 with a cubic inverse spinel structure. Transmission electron microscopy showed that the Fe3O4 nanoparticles were of spherical shape with a mean diameter of 11 nm, compared with 13 nm for the iron oxide-chitosan-gallic acid (FCG) nanocarriers. Conclusion: The magnetic nanocarrier enhanced the thermal stability of the drug, gallic acid. Release of the active drug from the FCG nanocarrier was found to occur in a controlled manner. The gallic acid and FCG nanoparticles were not toxic in a normal human fibroblast (3T3) line, and anticancer activity was higher in HT29 than MCF7 cell lines. © 2012 Cárdenas et al, publisher and licensee Dove Medical Press Ltd.
CITATION STYLE
Dorniani, D., Hussein, M. Z. B., Kura, A. U., Fakurazi, S., Shaari, A. H., & Ahmad, Z. (2012). Preparation of Fe3O4 magnetic nanoparticles coated with gallic acid for drug delivery. International Journal of Nanomedicine, 7, 5745–5756. https://doi.org/10.2147/IJN.S35746
Mendeley helps you to discover research relevant for your work.